| 0080068 | L-Carnitine Free & Total (Carnitine, Free & Total (Includes Carnitine, Esterified)) |
| 0080065 | L-Carnitine Free (Carnitine, Free) |
| 0080067 | L-Carnitine Total (Carnitine, Total) |
| 0091351 | L-Dopa (Levodopa, Serum or Plasma) |
| 0091464 | L Dopa (Paramethadione, Serum or Plasma) |
| 0080200 | L/S (Lecithin-Sphingomyelin Ratio) |
| 2003568 | L60 (CD43, L60 (Leu 22) by Immunohistochemistry) |
| 0050692 | La Antibody (SSB (La) (ENA) Antibody, IgG) |
| 0050508 | La Crosse Encephalitis (California Encephalitis Antibody, IgG by IFA, Serum) |
| 0098898 | La Crosse Encephalitis (California Encephalitis Antibody, IgM by IFA, CSF) |
| 0098731 | La Crosse Encephalitis (California Encephalitis Antibody, IgM by IFA, Serum) |
| 0098893 | La Crosse Encephalitis (California Encephalitis Antibody, IgG by IFA, CSF) |
| 0030075 | Labile Factor (Proaccelerin) (Factor V, Activity) |
| 2003182 | Lacosamide, (Vimpat®) Serum or Plasma
|
| 0020413 | Lactate Dehydrogenase, Isoenzymes
|
| 0020006 | Lactate Dehydrogenase, Serum or Plasma
|
| 0020505 | Lactate Dehydrogenase Total, Body Fluid
|
| 0020504 | Lactate (Lactic Acid, Body Fluid) |
| 0020516 | Lactate (Lactic Acid, CSF) |
| 0020045 | Lactate (Lactic Acid, Plasma) |
| 0020504 | Lactic Acid, Body Fluid
|
| 0020516 | Lactic Acid, CSF
|
| 0020045 | Lactic Acid, Plasma
|
| 0061164 | Lactoferrin, Fecal by ELISA
|
| 0020407 | Lactose Tolerance
|
| 2004680 | Lambda Interferon Genotyping (Interleukin 28 B (IL28B)-Associated Variants, 2 SNPs)
|
| 2003984 | Lambda Light Chains by Immunohistochemistry
|
| 0092628 | Lambert-Eaton (Voltage-Gated Calcium Channel (VGCC) Antibody) |
| 0080940 | Lamellar Body Count, Amniotic Fluid |
| 0080940 | Lamellar Body Counts
|
| 0090177 | Lamictal (Lamotrigine) |
| 2003987 | Laminin by Immunohistochemistry
|
| 2001961 | Laminopathies (LMNA) (Familial Mutation, Targeted Sequencing) |
| 2004543 | Laminopathies (LMNA-Related Disorders (LMNA) Sequencing)
|
| 0090177 | Lamotrigine
|
| 0090085 | Lanatoxin® (Digitoxin)
|
| 0090080 | Lanoxin (Digoxin) |
| 0049000 | LAP (Leukocyte Alkaline Phosphatase) |
| 0090870 | Largactil (Chlorpromazine) |
| 0091351 | Larodopa® (Levodopa, Serum or Plasma)
|
| 0091464 | Larodopa (Paramethadione, Serum or Plasma) |
| 0090158 | Laroxyl (Amitriptyline & Nortriptyline) |
| 0080467 | LASA (Lipid Associated Sialic Acid) |
| 0091263 | Lasix® (Furosemide, Serum or Plasma)
|
| 0091499 | Lasix (Loxapine, Urine) |
| 0091469 | Lasix{R}, Urine (Furosemide, Urine) |
| 0051729 | Latent Tuberculosis Infection (LTBI) (QuantiFERON®-TB Gold In Tube)
|
| 0092314 | Laudicon (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Laudicon (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0080940 | LBC (Lamellar Body Counts) |
| 2003574 | LCA (CD45 by Immunohistochemistry) |
| 0020413 | LD Isoenzymes (Lactate Dehydrogenase, Isoenzymes) |
| 0020006 | LD (Lactate Dehydrogenase, Serum or Plasma) |
| 0020505 | LD (Lactate Dehydrogenase Total, Body Fluid) |
| 0020413 | LDH Isoenzymes (Lactase Dehydrogenase, Isoenzymes) |
| 0020006 | LDH (Lactate Dehydrogenase, Serum or Plasma) |
| 0020257 | LDL Cholesterol, Direct
|
| 0020257 | LDL (LDL Cholesterol, Direct) |
| 0095263 | LDL Particle Size (VAP Cholesterol) |
| 0050021 | LDL Subclasses
|
| 0095263 | LDL Subfractions (VAP Cholesterol) |
| 0050021 | LDL Subtype (LDL Subclasses) |
| 2005287 | LE-Cell Factor (Chromatin Antibody, IgG) |
| 0020098 | Lead (Adult) (Lead, Blood (Venous)) |
| 0020745 | Lead, Blood (Capillary)
|
| 0020098 | Lead, Blood (Venous)
|
| 0090336 | Lead, Hair
|
| 0025016 | Lead, Industrial Exposure Panel, Adults
|
| 0090338 | Lead, Nails
|
| 0099470 | Lead (Pb) (Heavy Metals Panel 3, Blood) |
| 0099475 | Lead (Pb) (Heavy Metals Panel 3, Urine with Reflex to Arsenic Fractionated) |
| 0020584 | Lead (Pb) (Heavy Metals Panel 4, Blood) |
| 0020572 | Lead (Pb) (Heavy Metals Panel 4, Urine with Reflex to Arsenic Fractionated) |
| 0025055 | Lead (Pb) (Heavy Metals Panel 6, Urine with Reflex to Arsenic Fractionated) |
| 0025060 | Lead, Urine
|
| 0020745 | Lead (Pediatric) (Lead, Blood (Capillary)) |
| 0025060 | Lead/Creatinine Ratio, Random, Urine |
| 0025060 | LEADB (Lead, Urine) |
| 0080200 | Lecithin-Sphingomyelin Ratio
|
| 2004172 | Lectin (Ulex Europaeus Agglutinin 1 (UEA-1) by Immunohistochemistry) |
| 0049055 | Leder Stain (Esterase Stain, Specific) |
| 0093304 | Leflunomide (Teriflunomide), Blood
|
| 0093302 | Leflunomide (Teriflunomide), Serum or Plasma
|
| 0093306 | Leflunomide (Teriflunomide), Urine
|
| 0060113 | Legionella Culture |
| 0050376 | Legionella pneumophila Antibody (Type 1), IgG by IFA
|
| 0050273 | Legionella pneumophila Antibody (Type 1), IgM by IFA
|
| 0050365 | Legionella pneumophila Antibody (Types 1-6), IgG by IFA
|
| 0050274 | Legionella pneumophila Antibody (Types 1-6), IgM by IFA
|
| 0070322 | Legionella pneumophila Antigen, Urine
|
| 2004598 | Legionella pneumophila DFA
|
| 0056105 | Legionella pneumophila (Legionella Species by PCR)
|
| 2004598 | Legionella Smear, DFA (Legionella pneumophila DFA)
|
| 0056105 | Legionella Species by PCR
|
| 0060113 | Legionella Species, Culture
|
| 0070322 | Legionella Urinary Antigen (Legionella pneumophila Antigen, Urine)
|
| 2001961 | Legius Syndrome (SPRED1) and NF1 (Familial Mutation, Targeted Sequencing)
|
| 2002945 | Legius Syndrome (SPRED1) Sequencing and (NF1) Sequencing Exon 22 (Exon 17)
|
| 0051726 | Leishmania Antibody, IgG (Visceral Leishmaniasis)
|
| 0051726 | Leishmania donovani Antibodies (Leishmania Antibody, IgG (Visceral Leishmaniasis))
|
| 0051805 | Leopard Syndrome (Noonan Syndrome (PTPN11) Sequencing)
|
| 0098930 | Leponex (Clozapine) |
| 0070263 | Leptin
|
| 0050786 | Leptospira Antibody
|
| 0055233 | Leptospira Antibody, IgM by Dot Blot
|
| 0060158 | Leptospira Culture
|
| 2003568 | Leu 22 (CD43, L60 (Leu 22) by Immunohistochemistry) |
| 2003592 | Leu7 (CD57 by Immunohistochemistry) |
| 0080301 | Leucine Aminopeptidase (LAP), Serum
|
| 0093194 | Leukemia/Lymphoma Phenotyping (Chronic Lymphocytic Leukemia Follow up Phenotyping by Flow Cytometry) |
| 0095244 | Leukemia/Lymphoma Phenotyping (Comprehensive - Bone Marrow)
|
| 0095243 | Leukemia/Lymphoma Phenotyping (Comprehensive - Miscellaneous)
|
| 0096299 | Leukemia/Lymphoma Phenotyping (Comprehensive - Whole Blood)
|
| 2004359 | Leukocyte Adhesion Deficiency Panel
|
| 0049000 | Leukocyte Alkaline Phosphatase
|
| 0099603 | Leukocyte Lysosomal Enzyme
|
| 2003568 | Leukosialin (CD43, L60 (Leu 22) by Immunohistochemistry) |
| 2003529 | LeuM1 (CD15, Leu M1 by Immunohistochemistry) |
| 0098627 | Levetiracetam (Keppra® (Levetiracetam))
|
| 0091351 | Levodopa, Serum or Plasma
|
| 0051104 | Lexapro ( Cytochrome P450 2C19 (CYP2C19) 9 Mutations)
|
| 0092382 | Lexapro (Escitalopram, Serum or Plasma) |
| 0070193 | LH/FSH (Luteinizing Hormone and Follicle Stimulating Hormone) |
| 0070093 | LH (Luteinizing Hormone, Serum) |
| 0090148 | Librax (Librium and Nordiazepam) |
| 0090148 | Libritabs (Librium and Nordiazepam) |
| 0090148 | Librium & Nordiazepam
|
| 0090148 | Librium and Metabolite (Librium and Nordiazepam) |
| 0092520 | Librium (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Librium (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Librium (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0092572 | Lichen & Lichenoid (Cutaneous Direct Immunofluorescence, Biopsy) |
| 0090155 | Lidocaine
|
| 0091197 | Lidocaine & Metabolite, Serum or Plasma
|
| 0091198 | Lidocaine and Metabolite, Urine
|
| 2002756 | Lidol (Meperidine & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2002760 | Lidol (Meperidine & Metabolite - Confirmation/Quantitation - Urine) |
| 0091450 | Lidone® (Molindone Quantitation, Urine)
|
| 0091451 | Lidone® (Molindone, Serum or Plasma)
|
| 2004539 | Limb Girdle Muscular Dystrophy 1B (LMNA-Related Disorders (LMNA) Deletion/Duplication)
|
| 2004543 | Limb Girdle Muscular Dystrophy 1B (LMNA-Related Disorders (LMNA) Sequencing)
|
| 0090158 | Limbitrol (Amitriptyline & Nortriptyline) |
| 0097328 | Limulus Amebocyte Lysate (LAL)
|
| 0092572 | Linear IgA Bullous, Tissue (Cutaneous Direct Immunofluorescence, Biopsy) |
| 2005275 | Lioresal (Baclofen Quantitation, Fluid) |
| 2005273 | Lioresal (Baclofen Quantitation, Serum or Plasma) |
| 0020715 | Lipase, Fluid
|
| 0020014 | Lipase, Serum or Plasma
|
| 0080467 | Lipid Associated Sialic Acid
|
| 0020421 | Lipid Panel
|
| 0020468 | Lipid Panel, Extended
|
| 0092252 | Lipid Peroxides (TBARS), Serum
|
| 0098711 | Lipid Profile, Ultracentrifuge
|
| 2002043 | LipoMed (NMR LipoProfile® Test)
|
| 0099174 | Lipoprotein (a)
|
| 2002043 | Lipoprotein Analysis (LDL-P, HDL-P, VLDL-P, LDL Size), Expanded (NMR LipoProfile® Test)
|
| 0080503 | Lipoprotein Electrophoresis
|
| 0080570 | Lipoprotein Electrophoresis with Qualitative Band Assessment
|
| 0081055 | Lipoprotein-Associated Phospholipase A2 (PLAC®)
|
| 2002299 | LIS1 (Chromosome FISH, Metaphase) |
| 0091372 | Lisdexamfetamine (Drugs of Abuse Confirmation/Quantitation - Amphetamine- Serum or Plasma) |
| 0092310 | Lisdexamfetamine (Drugs of Abuse Confirmation/Quantitation - Amphetamines (Amphetamine & Methamphetamine) - Meconium)
|
| 0090439 | Lisdexamfetamine (Drugs of Abuse Confirmation/Quantitation - Amphetamines - Urine) |
| 2002086 | Listeria Antibody, CSF by CF
|
| 0099529 | Listeria Antibody, Serum by CF
|
| 0020038 | Lithium, Serum or Plasma
|
| 0020416 | Liver Function Panel (Hepatic Function Panel) |
| 0055241 | Liver-Kidney Microsome - 1 Antibody, IgG
|
| 0099270 | Liver-Kidney Microsome Antibody, IgG
|
| 0099270 | LKM IgG Antibodies (Liver-Kidney Microsome Antibody, IgG) |
| 2004539 | LMNA-Related Disorders (LMNA) Deletion/Duplication
|
| 2004543 | LMNA-Related Disorders (LMNA) Sequencing
|
| 2005629 | LMW Heparin (Serotonin Release Assay (Heparin Dependent Platelet Antibody), Low Molecular Weight Heparin)
|
| 0049025 | Loa loa Smear (Parasites Smear (Giemsa Stain), Blood) |
| 2002697 | Loeys-Dietz Syndrome (TGBR1 & TGBR2) Deletion/Duplication
|
| 2001961 | Loeys-Dietz Syndrome (TGFBR1 & TGFBR2) (Familial Mutation, Targeted Sequencing)
|
| 2002705 | Loeys-Dietz Syndrome (TGFBR1 & TGFBR2) Sequencing
|
| 2002701 | Loeys-Dietz Syndrome (TGFBR1 & TGFBR2) Sequencing & Deletion/Duplication
|
| 0095302 | Long-Chain Fatty Acids (LCFA) (Fatty Acids Profile, Essential (C12-C22)) |
| 0091453 | Lopressor® (Metoprolol (Lopressor®), Serum or Plasma)
|
| 0091452 | Lopressor® (Metoprolol (Lopressor®), Urine)
|
| 0091204 | Lopurin (Allopurinol, Serum or Plasma) |
| 0090364 | Loracet (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0090181 | Lorazepam
|
| 0092520 | Lorazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Lorazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Lorazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0092314 | Lorcet (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0092314 | Lortab (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Lortab (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0060247 | Louse (Parasite Examination, Macroscopic) |
| 2005629 | Lovenox (Serotonin Release Assay (Heparin Dependent Platelet Antibody), Low Molecular Weight Heparin)
|
| 0050029 | Low Density Lipoprotein (Apolipoprotein B) |
| 0050029 | Low Density Lipoprotein, B (Apolipoprotein B) |
| 0020257 | Low Density Lipoprotein (LDL Cholesterol, Direct) |
| 0050021 | Low Density Lipoprotein Subclass Pattern (LDL Subclasses) |
| 0091295 | Loxapine, Serum or Plasma
|
| 0091499 | Loxapine, Urine
|
| 0091295 | Loxitane® (Loxapine, Serum or Plasma)
|
| 0091499 | Loxitane® (Loxapine, Urine)
|
| 0091402 | Loxitane (Pentachlorophenol, Urine) |
| 0099174 | Lp(a) (Lipoprotein (a)) |
| 0081055 | LpPLA (Lipoprotein-Associated Phospholipase A2 (PLAC™Test))
|
| 0081055 | LpPLA2 (Lipoprotein-Associated Phospholipase A2 (PLAC™Test))
|
| 0080200 | LS Ratio (Lecithin-Sphingomyelin Ratio) |
| 0091200 | LSD-25 (LSD, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation) |
| 0091224 | LSD-25 (LSD, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0091200 | LSD, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation
|
| 0091224 | LSD, Urine - Screen with Reflex to Confirmation/Quantitation
|
| 0096048 | Ludiomil (Antidepressant Panel Quantitation, Urine) |
| 0091503 | Lufyllin (Dyphylline Quantitative, Urine) |
| 0092311 | Luminal (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Meconium) |
| 0093308 | Luminal (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Serum or Plasma) |
| 0090357 | Luminal (Drugs of Abuse Confirmation/Quantitation - Barbiturates - Urine) |
| 0090230 | Luminal (Phenobarbital) |
| 0091551 | Luminal® (Phenobarbital, Free & Total, Serum or Plasma)
|
| 0091565 | Luminal® (Phenobarbital, Serum or Plasma)
|
| 2006029 | Lung Cancer Mutation Reflexive Panel
|
| 2006102 | Lung Cancer, ALK (2p23) Rearrangement, FISH, Tissue |
| 2006102 | Lung carcinoma |
| 0030181 | Lupus 1 (Lupus Anticoagulant Reflexive Panel) |
| 0050317 | Lupus (Anti-Nuclear Antibody (ANA), IgG by ELISA with Reflexes to ANA by IFA and to dsDNA, RNP, Smith, SSA, and SSB Antibodies)
|
| 0030181 | Lupus Anticoagulant Comprehensive (Lupus Anticoagulant Reflexive Panel) |
| 0030181 | Lupus Anticoagulant Reflexive Panel
|
| 0050119 | Lupus Comprehensive Reflexive Panel
|
| 0092572 | Lupus Erythematous, Tissue (Cutaneous Direct Immunofluorescence, Biopsy) |
| 0030181 | Lupus Inhibitor (Lupus Anticoagulant Reflexive Panel) |
| 0050317 | Lupus Screen (Anti-Nuclear Antibody (ANA), IgG by ELISA with Reflexes to ANA by IFA and to dsDNA, RNP, Smith, SSA, and SSB Antibodies)
|
| 0098745 | Lustral (Sertraline) |
| 0021021 | Lutein (Carotenes, Fractionated, Plasma or Serum) |
| 0070193 | Luteinizing Hormone and Follicle Stimulating Hormone
|
| 2005166 | Luteinizing Hormone, Pediatric
|
| 0020780 | Luteinizing Hormone, Pooled
|
| 0070093 | Luteinizing Hormone, Serum
|
| 0091234 | Luvox® (Fluvoxamine, Serum or Plasma)
|
| 0050253 | Lyme Ab (Borrelia burgdorferi Antibody, IgM by Western Blot)
|
| 0050254 | Lyme Antibodies (Borrelia burgdorferi Antibodies, IgG & IgM by Western Blot)
|
| 0050216 | Lyme Antibodies Detection (Borrelia burgdorferi Antibodies, Total by ELISA)
|
| 0099483 | Lyme Antibodies, Total (Borrelia burgdorferi Antibodies, Total by ELISA (CSF))
|
| 0050255 | Lyme Antibody (Borrelia burgdorferi Antibody, IgG by Western Blot)
|
| 0050267 | Lyme Disease, Acute Reflexive Panel (Borrelia burgdorferi Antibodies, Total by ELISA with Reflex to IgG & IgM by Western Blot (Early Disease))
|
| 0050254 | Lyme Disease (Borrelia burgdorferi Antibodies, IgG & IgM by Western Blot)
|
| 0055260 | Lyme Disease (Borrelia burgdorferi Antibodies, IgG & IgM by Western Blot (CSF))
|
| 0050216 | Lyme Disease (Borrelia burgdorferi Antibodies, Total by ELISA)
|
| 0099483 | Lyme Disease (Borrelia burgdorferi Antibodies, Total by ELISA (CSF))
|
| 0050267 | Lyme Disease (Borrelia burgdorferi Antibodies, Total by ELISA with Reflex to IgG & IgM by Western Blot (Early Disease))
|
| 0050255 | Lyme Disease (Borrelia burgdorferi Antibody, IgG by Western Blot)
|
| 0055259 | Lyme Disease (Borrelia burgdorferi Antibody, IgG by Western Blot (CSF))
|
| 0050253 | Lyme Disease (Borrelia burgdorferi Antibody, IgM by Western Blot)
|
| 0055258 | Lyme Disease (Borrelia burgdorferi Antibody, IgM by Western Blot (CSF))
|
| 0051044 | Lyme Disease (Borrelia burgdorferi C6 Peptide Antibodies, Total by ELISA)
|
| 0051046 | Lyme Disease (Borrelia burgdorferi C6 Peptide Antibodies, Total by ELISA (CSF))
|
| 0051043 | Lyme Disease (Borrelia burgdorferi C6 Peptide Antibodies, Total by ELISA with Reflex to IgG & IgM by Western Blot)
|
| 0051045 | Lyme Disease (Borrelia burgdorferi C6 Peptide Antibodies, Total by ELISA with Reflex to IgG by Western Blot)
|
| 0050268 | Lyme Disease (Borrelia burgdorferi Total Antibodies, IgG and/or IgM by ELISA with Reflex to IgG by Western Blot (Late Disease))
|
| 0055570 | Lyme Disease (Borrelia Species DNA Detection by PCR (Lyme Disease))
|
| 0050268 | Lyme Disease Chronic Reflexive Panel (Borrelia burgdorferi Total Antibodies, IgG and/or IgM by ELISA with Reflex to IgG by Western Blot (Late Disease))
|
| 0096056 | Lymphocyte Antigen & Mitogen Proliferation Panel
|
| 0051584 | Lymphocyte Antigen and Mitogen Proliferation Panel with Cytokine Response to Mitogens, 12 Cytokines
|
| 0051587 | Lymphocyte Antigen and Mitogen Proliferation Panel with Cytokine Response to Mitogens, Monokines
|
| 0051585 | Lymphocyte Antigen and Mitogen Proliferation Panel with Cytokine Response to Mitogens, TH1 Cytokines
|
| 0051586 | Lymphocyte Antigen and Mitogen Proliferation Panel with Cytokine Response to Mitogens, TH2 Cytokines
|
| 0096055 | Lymphocyte Antigen Proliferation
|
| 0096056 | Lymphocyte Blastogenesis (Lymphocyte Antigen & Mitogen Proliferation Panel) |
| 0096043 | Lymphocyte Mitogen Proliferation
|
| 0095853 | Lymphocyte Subset CD4 and CD8 (Lymphocyte Subset Panel 3-T-Cell Subsets (CD4 & CD8), Absolute Count) |
| 0095854 | Lymphocyte Subset Panel 1 - CD4 Absolute Count Only
|
| 0095885 | Lymphocyte Subset Panel 2 - CD4 Percent and Absolute
|
| 0095853 | Lymphocyte Subset Panel 3 - T-Cell Subsets (CD4 and CD8), Absolute Counts Only
|
| 0095950 | Lymphocyte Subset Panel 4 - T-Cell Subsets Percent and Absolute, Whole Blood
|
| 0093420 | Lymphocyte Subset Panel 4 - T-Cell Subsets Percents and Ratio, Bronchoalveolar Lavage
|
| 0095892 | Lymphocyte Subset Panel 5 - Total Lymphocyte Enumeration
|
| 0095862 | Lymphocyte Subset Panel 6 - Total Lymphocyte Enumeration with CD45RA and CD45RO
|
| 0095899 | Lymphocyte Subset Panel 7 - Congenital Immunodeficiencies
|
| 0095949 | Lymphocyte Transplantation CD3
|
| 0095798 | Lymphocyte Transplantation Profile
|
| 2001635 | Lymphocytic Choriomeningitis (LCM) Virus Antibodies, IgG & IgM
|
| 2001628 | Lymphocytic Choriomeningitis (LCM) Virus Antibodies, IgG & IgM, CSF
|
| 2001633 | Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgG
|
| 2001629 | Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgG, CSF
|
| 2001634 | Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgM
|
| 2001630 | Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgM, CSF
|
| 0098880 | Lymphogranuloma Venereum (LGV), Differentiation Antibody Panel, MIF
|
| 2002650 | Lymphoma (Aggressive) Panel by FISH
|
| 0051654 | Lynch Syndrome (HNPCC/Lynch Syndrome (MSH2) Sequencing and Deletion/Duplication)
|
| 2001728 | Lynch Syndrome/HNPCC (HNPCC/Lynch Syndrome Deletion/Duplication) |
| 0051650 | Lynch Syndrome (HNPCC/Lynch Syndrome (MLH1) Sequencing and Deletion/Duplication)
|
| 0051737 | Lynch Syndrome (HNPCC/Lynch Syndrome (PMS2) Sequencing and Deletion/Duplication)
|
| 2001961 | Lynch Syndrome/HNPCC (MLH1) (Familial Mutation, Targeted Sequencing)
|
| 2001961 | Lynch Syndrome/HNPCC (MSH2) (Familial Mutation, Targeted Sequencing)
|
| 2001961 | Lynch Syndrome/HNPCC (MSH6) (Familial Mutation, Targeted Sequencing)
|
| 2001961 | Lynch Syndrome/HNPCC (PMS2) (Familial Mutation, Targeted Sequencing)
|
| 0051740 | Lynch Syndrome/Microsatellite Instability (HNPCC/Lynch Syndrome, Microsatellite Instability by PCR) |
| 0049302 | Lynch Syndrome/Microsatellite Instability (Mismatch Repair by Immunohistochemistry) |
| 2005270 | Lynch Syndrome/Microsatellite Instability (Mismatch Repair by Immunohistochemistry with Reflex to MLH1 Promoter Methylation)
|
| 2002327 | Lynch Syndrome (Mismatch Repair by Immunohistochemistry with Reflex to BRAF Codon 600 Mutation and MLH1 Promoter Methylation)
|
| 0051656 | Lynch Syndrome (MSH6) Sequencing and Deletion/Duplication (HNPCC/Lynch Syndrome (MSH6) Sequencing and Deletion/Duplication)
|
| 0099906 | Lyogen (Fluphenazine) |
| 2002554 | Lyrica® (Pregabalin, Serum or Plasma)
|
| 0092520 | Lysanxia (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Lysanxia (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Lysanxia (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0091200 | Lysergide (LSD, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation) |
| 0091224 | Lysergide (LSD, Urine - Screen with Reflex to Confirmation/Quantitation) |
| 0099603 | Lysosomal Enzyme Panel (Leukocyte Lysosomal Enzyme) |
| 0099603 | Lysosomal Storage Disease Enzyme Analysis (Leukocyte Lysosomal Enzyme) |
| 2003990 | Lysozyme (Muramidase) by Immunohistochemistry
|
| 0050367 | Lysozyme, Serum or Body Fluid
|
| 0050368 | Lysozyme, Urine
|